Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (LYEL)

CUSIP: 55083R104

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+2,155,197
Put/Call ratio
207%
SEC-reported price per share
$0.54
Number of holders
111
Value change
+$815,972
Number of buys
37
Open additional details 1 more signal available
Number of sells
40
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
23,360,878

Security key

55083R104

Report period

Q1 2025

Institutions

111

Top holders

10

Ownership snapshot

Top reported holders of LYEL - Lyell Immunopharma, Inc. - Common Stock par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Foresite Capital Fund IV,...
Disclosed value leader
MWG Management Ltd.
Comparable rows
15/15
Latest evidence
31 Mar 2025
13D/G 13F Lead comparable stake: 9.2% 13D/G row: Foresite Capital Fund IV, L.P. Showing 1-6 of 15 holder rows.

Quick read

Foresite Capital Fund IV, L.P. leads the comparable SEC ownership view at 9.2%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Foresite Capital Fund IV, L.P.'s linked filing trail.
Comparable ownership Top 5
Foresite Capital Fund IV, L.P. 9.2%
BlackRock, Inc. 4.5%
MWG Management Ltd. 86%
Orland Properties Ltd 65%
Decheng Capital LLC 51%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Foresite Capital Fund IV, L.P.
13D/G
James B. Tananbaum
9.2%
$12,766,089
27,161,892 shares
+$3,611,010 31 Mar 2025
BlackRock, Inc.
13F 13D/G
Company
4.5%
from 13D/G
$8,490,156
13,265,869 shares
31 Dec 2024
MWG Management Ltd.
13F
Company
13F
86%
$12,903,892
20,162,332 shares
31 Dec 2024
Orland Properties Ltd
13F
Company
13F
65%
$9,660,140
15,093,969 shares
31 Dec 2024
Decheng Capital LLC
13F
Company
13F
51%
$7,621,978
11,909,341 shares
31 Dec 2024
VANGUARD GROUP INC
13F
Company
13F
42%
$6,250,292
9,766,083 shares
31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
111
Shares
152,354,676
Rows available
111
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q4 2025 Across Filers

Q4 2025 holders
1
Q1 2025 holders
111
Holder diff
110
Investor Q4 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2025 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .